Satellos Bioscience Inc.
MSCLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $85 | $84 | $94 | $96 |
| - Cash | $19 | $38 | $33 | $58 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $65 | $46 | $61 | $38 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$7 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.034 | -0.045 | -0.053 | -0.054 |
| % Growth | 22.9% | 16.3% | 1.3% | – |
| Operating Cash Flow | -$4 | -$5 | -$7 | -$8 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$4 | -$5 | -$7 | -$8 |